Hudson, MA, May 24, 2019 – Proveris Scientific Corporation, a leading provider of services and technology to advance the science of respiratory drug delivery products, today announced the addition of new services to accelerate product characterization, performance, safety and bioequivalence testing of inhalation drug products by measuring the aerosolization process, regional deposition and bioavailability under more human realistic conditions than existing methods.
These services are aligned with recent efforts to establish in-vitro/in-vivo correlation (IVIVC) and support the FDA’s newly released draft guidance on Beclomethasone Dipropionate that promotes alternate in-vitro studies in lieu of clinical endpoint.
Based on an innovative new proprietary technology, these services have been developed in collaboration with key industry leaders and are now being offered through Proveris Labs.
“We are very excited to offer our customers access to this new technology” comments Alberto Correia, Vice President of Technical Services, “we believe we will provide our customers tremendous insight into the performance of their products and enable a new approach to IVIVC.”
About Proveris Scientific
Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis while leveraging their expertise, experience and core technologies. With customers’ success as their central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” that include product innovation, technical services, systems, consumables and educational training.
Since its founding in 1995, the company has accelerated the development of the top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc. and has more than 20 patents on its technology issued in United States, Europe, and Asia. For more information, please visit www.proveris.com.